ONCOZ Share Price Performance
SEK 6.85
0.74 (12.11%)
Price SEK 6.85
Share Pricen/a
OncoZenge AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
ONCOZ Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
OncoZenge AB (publ) Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Sep 03, 2026
- -1.65
- 100.00%
- -32,557.75%
- 2,095.0%
About ONCOZ
- Founded
- 2020
- Employees
- 1
- CEO
- WebsiteView website
OncoZenge AB (publ), is a clinical-stage pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. The company offers BupiZenge, which is in Phase 3 clinical trials for the treatment of pain in the oral cavity. The company was founded in 2020 and is headquartered in Bromma, Sweden.
